Omaciclovir (H2G) is a potent and selective inhibitor of herpesvirus replication; it exhibits in vitro antiviral activity against varicella-zoster virus (VZV), herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), Epstein-Barr virus, and human herpesvirus 6; it is also efficacious in simian varicella virus-infected monkeys.